This hypothesis is supported by Teixeira et al., who reported increased levels of bacterial translocation markers like LPS and CD14 in patients with COVID-19 pneumonia compared to patients with bacterial pneumonia, as well as amongst COVID-19 non-survivors and survivors18. This evidence concerns the gene CD14 and bacterial pneumonia.